Inclusion Criteria:

• Women ≥ 22 years old
• Bothersome OAB symptoms (defined as bother rating ≥ 5 on ICIQ-FLUTS question #3b or #9b)
• English-speaking
• Willing to forego other treatment outside of medications for the 8-week trial period
• Use of at least one mobile App

Exclusion Criteria:

• Stress-predominant mixed urinary incontinence (defined as QUID stress score > QUID urge score)

• Voiding dysfunction defined as response ≥ 2 on ICIQ-FLUTS question #7a

• Bladder pain defined as response ≥ 2 on ICIQ-FLUTS question #4a

• Use of an OAB medication (anticholinergic or beta-agonist) within the past two weeks

• Currently using intermittent or indwelling catheter

• History of bladder/urethral, colon/anal, or cervical cancer

• Current or prior use of sacral neuromodulation, tibial stimulation or onabotulinum toxin type A intradetrusor injection

• Currently taking antibiotics/drugs for urinary tract infection^

• Currently undergoing or unwilling to forego pelvic floor physical therapy with a physical therapist or prescription device for the 8-week intervention period

• Planning surgery for pelvic organ prolapse within 12 months of randomization

• Pelvic surgery within the past 6 months

• Planning to undergo pessary fitting °

  • Those on antibiotics for urinary tract infection will be eligible for enrollment 2 weeks after completing antibiotic therapy with subjective resolution of UTI symptoms °Will be eligible after completing pessary fitting

https://researchdata.medstar.net/redcap/surveys/?s=MM7WN7EXACX4PNXJ